Clinical Trial: Phase 1/2 Study of Intravenous Injection of STX-003 in Advanced Solid Tumors as Monotherapy or in Combination With Pembrolizumab

U.S., Aug. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07751042) titled 'Phase 1/2 Study of Intravenous Injection of STX-003 in Advanced Solid Tumors as Monotherapy or in Combination With Pembrolizumab' on April 06.

Brief Summary: Phase 1/2, Open-label, Multi-center, First-in-human Study of the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Anti-tumor Activity of STX-003 Delivered by Intravenous Injection in Patients with Advanced Solid Tumors as a Monotherapy or in Combination with Pembrolizumab.

Study Start Date: June 30

Study Type: INTERVENTIONAL

Condition: Advanced Solid Tumor

Intervention: BIOLOGICAL: STX-003

STX-003 is a LNP formulated self-replicating mRNA encoding the therapeu...